Environmental oxygen tension affects phenotype in cultured bone marrow-derived macrophages

被引:26
|
作者
Pfau, JC [1 ]
Schneider, JC [1 ]
Archer, AJ [1 ]
Sentissi, J [1 ]
Leyva, FJ [1 ]
Cramton, J [1 ]
机构
[1] Univ Montana, Environm Hlth Sci Ctr, Dept Biomed & Pharmaceut Sci, Missoula, MT 59812 USA
关键词
redox; alveolar macrophage; glutathione; nuclear factor-kappa B;
D O I
10.1152/ajplung.00380.2002
中图分类号
Q4 [生理学];
学科分类号
071003 ;
摘要
This study tested the hypothesis that the unique phenotype of alveolar macrophages (AM) is maintained through adaptation to the relatively high oxygen partial pressure (Po-2) of the lung, through modification of redox-sensitive transcription factors. BALB/c mouse bone marrow-derived macrophages (BMC) were differentiated under different Po-2 and compared functionally to AM and peritoneal macrophages ( PM). BMC differentiated in normoxia (Po-2 140 Torr, BMChigh) were similar to AM in having low phagocytic and antigen presenting cell (APC) activities. However, BMC grown in low oxygen tension as found in other tissues ( < 40 Torr, BMClow) were better phagocytes and APCs, similar to PM. BMChigh were more oxidative intracellularly than BMClow, based on oxidation of dichlorofluorescein and higher glutathione disulfide/glutathione (GSH) ratios, despite having more GSH. Finally, lipopolysaccharide-induced nuclear factor-κB translocation, measured by laser scanning cytometry, was reduced in BMChigh and AM, compared with BMClow and PM, respectively. These data suggest that regulation of the AM phenotype may occur, at least in part, via inhibition of NF-κB by the unique redox environment.
引用
收藏
页码:L354 / L362
页数:9
相关论文
共 50 条
  • [31] SURFACE PHENOTYPE OF RAT BONE MARROW-DERIVED MONONUCLEAR PHAGOCYTES
    KELLER, R
    JOLLER, PW
    KEIST, R
    CELLULAR IMMUNOLOGY, 1989, 120 (01) : 277 - 285
  • [32] A Method for Generation of Bone Marrow-Derived Macrophages from Cryopreserved Mouse Bone Marrow Cells
    Marim, Fernanda M.
    Silveira, Tatiana N.
    Lima, Djalma S., Jr.
    Zamboni, Dario S.
    PLOS ONE, 2010, 5 (12): : 1 - 8
  • [33] Antineoplastic therapy affects the in vitro phenotype and functionality of healthy human bone marrow-derived mesenchymal stromal cells
    Scherer, Bo
    Bogun, Lucienne
    Koch, Annemarie
    Jaeger, Paul
    Maus, Uwe
    Schmitt, Laura
    Krings, Karina S.
    Wesselborg, Sebastian
    Haas, Rainer
    Schroeder, Thomas
    Geyh, Stefanie
    ARCHIVES OF TOXICOLOGY, 2025, 99 (01) : 393 - 406
  • [34] Phenotypic changes in bone marrow-derived murine macrophages cultured on PEG-based hydrogels activated or not by lipopolysaccharide
    Lynn, Aaron D.
    Bryant, Stephanie J.
    ACTA BIOMATERIALIA, 2011, 7 (01) : 123 - 132
  • [35] Pig Bone Marrow-Derived Macrophages Resemble Human Macrophages in Their Response to Bacterial Lipopolysaccharide
    Kapetanovic, Ronan
    Fairbairn, Lynsey
    Beraldi, Dario
    Sester, David P.
    Archibald, Alan L.
    Tuggle, Christopher K.
    Hume, David A.
    JOURNAL OF IMMUNOLOGY, 2012, 188 (07): : 3382 - 3394
  • [36] MODULATION OF THE ANTIGEN PROCESSING CAPACITY OF BONE MARROW-DERIVED MACROPHAGES BY LYMPHOKINES
    RESKEKUNZ, AB
    FROSCH, S
    BONIFAS, U
    JOURNAL OF CELLULAR BIOCHEMISTRY, 1993, : 72 - 72
  • [37] GENERATION AND FUNCTIONAL-CHARACTERIZATION OF OVINE BONE MARROW-DERIVED MACROPHAGES
    FRANCEY, T
    SCHALCH, L
    BRCIC, M
    PETERHANS, E
    JUNGI, TW
    VETERINARY IMMUNOLOGY AND IMMUNOPATHOLOGY, 1992, 32 (3-4) : 281 - 301
  • [38] BONE MARROW-DERIVED MACROPHAGES - A MODEL FOR INTERFERON-INDUCED DIFFERENTIATION
    VOGEL, SN
    WARREN, MK
    LYMPHOKINE RESEARCH, 1984, 3 (04): : 278 - 278
  • [39] CF BONE MARROW-DERIVED MACROPHAGES BEHAVE LIKE WT IN CULTURE
    Hao, S.
    Mai, W.
    Roesch, E. A.
    Henderson, L. C.
    Eastman, J.
    Li, Y.
    Drumm, M. L.
    PEDIATRIC PULMONOLOGY, 2016, 51 : 342 - 343
  • [40] GETTING TO THE CORE OF MICROGLIA VERSUS BONE MARROW-DERIVED MACROPHAGES IN GLIOBLASTOMA
    Woolf, Z. R.
    Smith, A.
    Swanson, M. E., V
    Scotter, E. L.
    Schweder, P.
    Correia, J.
    Park, T., I
    Dragunow, M.
    NEURO-ONCOLOGY, 2022, 24